Providence Medical Technology Announces FDA 510(k) Clearance for DTRAX® Spinal System - Providence - Providence Medical Technology

Providence Medical Technology, Inc. today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its DTRAX® Spinal System to be specifically indicated for use in posterior cervical fusion in patients with cervical degenerative disc disease.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2022, Providence Medical Technology. All rights reserved.